(Unit: thousands of yen)
FY2023 For the nine months ended December 31, 2023 |
FY2024 For the nine months ended December 31, 2024 |
||
Net sales |
38,544,834 |
43,102,644 |
|
Cost of sales |
31,342,203 |
34,597,102 |
|
Gross profit |
7,202,631 |
8,505,542 |
|
Selling, general and administrative expenses |
|||
Advertising expenses |
81,659 |
108,462 |
|
Remuneration, salaries and allowances for directors (and other officers) |
1,635,349 |
1,678,898 |
|
Provision for bonuses |
107,481 |
117,168 |
|
Retirement benefit expenses |
44,587 |
39,639 |
|
Provision for retirement benefits for directors (and other officers) |
- |
390 |
|
Legal welfare expenses |
249,084 |
271,251 |
|
Hiring expenses |
143,737 |
176,063 |
|
EucationExpense |
155,935 |
118,662 |
|
Entertainment expenses |
54,296 |
62,528 |
|
Rent expenses on land and buildings |
140,104 |
167,133 |
|
Supplies expenses |
61,671 |
66,869 |
|
Enterprise tax |
158,767 |
166,059 |
|
Other |
1,071,666 |
1,378,258 |
|
Total selling, general and administrative expenses |
3,904,341 |
4,351,384 |
|
Operating profit |
3,298,289 |
4,154,157 |
|
Non-operating income |
|||
Interest income |
202,280 |
183,432 |
|
Dividend income |
64,171 |
67,753 |
|
Gain on sales of securities |
5,444 |
17,464 |
|
Gain on valuation of securities |
2,692 |
- |
|
Gain on investments in money held in trust |
19,370 |
3,964 |
|
Gain on valuation of derivatives |
301,645 |
30,103 |
|
Subsidy income |
28,202 |
40,316 |
|
Share of profit of entities accounted for using equity method |
37,572 |
42,938 |
|
Other |
29,524 |
36,496 |
|
Total non-operating income |
690,904 |
422,470 |
|
Non-operating expenses |
|||
Interest expenses |
1,978 |
8,658 |
|
Loss on valuation of securities |
- |
29,784 |
|
Foreign exchange losses |
26,429 |
68 |
|
Investment advisory fee |
67,826 |
96,354 |
|
Other |
5,260 |
15,341 |
|
Total non-operating expenses |
101,495 |
150,207 |
|
Ordinary profit |
3,887,699 |
4,426,420 |
|
Extraordinary income |
|||
Gain on sales of investment securities |
4,854 |
57,074 |
|
Gain on redemption of investment securities |
108,001 |
57,315 |
|
Surrender value of insurance policies |
10,520 |
6,258 |
|
Gain on sale of shares of subsidiaries and associates |
- |
1,626 |
|
Other |
- |
3,197 |
|
Total extraordinary income |
123,375 |
125,472 |
|
Extraordinary losses |
|||
Loss on retirement of non-current assets |
3,043 |
15,939 |
|
Loss on sale of investment securities |
759 |
5,343 |
|
Loss on valuation of investment securities |
5,807 |
23,209 |
|
Office relocation expenses |
1,755 |
33,947 |
|
Provision for compensation losses |
- |
86,000 |
|
Impairment losses |
209,564 |
- |
|
Other |
31,053 |
27,155 |
|
Total extraordinary losses |
251,984 |
191,594 |
|
Profit before income taxes |
3,759,089 |
4,360,298 |
|
Income taxes - current |
1,095,554 |
1,136,725 |
|
Income taxes - deferred |
265,390 |
296,762 |
|
Total income taxes |
1,360,945 |
1,433,487 |
|
Profit |
2,398,144 |
2,926,810 |
|
Profit attributable to non-controlling interests |
- |
- |
|
Profit attributable to owners of parent |
2,398,144 |
2,926,810 |
(Unit: yen)
FY2023 End of consolidated accounting period (As of March 31, 2024) |
FY2024 End of Third quarter consolidated accounting periodperiod (As of December 31, 2024) |
|
Research and development costs |
83,143,917 |
64,115,639 |
(Unit: thousands of yen)
FY2023 For the nine months ended December 31, 2023 |
FY2024 For the nine months ended December 31, 2024 |
||
Profit |
2,398,144 |
2,926,810 |
|
Other comprehensive income |
|||
Valuation difference on available-for-sale securities |
607,098 |
859,946 |
|
Foreign currency translation adjustment |
1,959 |
699 |
|
Remeasurements of defined benefit plans, net of tax |
-10,817 |
-27,361 |
|
Total other comprehensive income |
598,239 |
833,284 |
|
Comprehensive income |
2,996,384 |
3,760,094 |
|
Comprehensive income attributable to |
|||
Comprehensive income attributable to owners of parent |
2,996,384 |
3,760,094 |
|
Comprehensive income attributable to non-controlling interests |
- |
- |
※Please note the following:
・The data used within this site is compiled from the corporate prospectus and earnings announcements.
・This site may not be immediately rectified as correction of earnings data and others.
Download Key Financial Data
-
Download EXCEL data (15KB)